Chong Kun Dang Pharmaceutical (XKRX:185750) Other Stockholders Equity : ₩-7,932 Mil (As of Mar. 2024)

View and export this data going back to 2013. Start your Free Trial

What is Chong Kun Dang Pharmaceutical Other Stockholders Equity?

Chong Kun Dang Pharmaceutical's Other Stockholders Equity for the quarter that ended in Mar. 2024 was ₩-7,932 Mil.

Chong Kun Dang Pharmaceutical's quarterly Other Stockholders Equity increased from Sep. 2023 (₩-14,369 Mil) to Dec. 2023 (₩-8,070 Mil) and increased from Dec. 2023 (₩-8,070 Mil) to Mar. 2024 (₩-7,932 Mil).

Chong Kun Dang Pharmaceutical's annual Other Stockholders Equity declined from Dec. 2021 (₩-8,567 Mil) to Dec. 2022 (₩-14,217 Mil) but then increased from Dec. 2022 (₩-14,217 Mil) to Dec. 2023 (₩-8,070 Mil).

Chong Kun Dang Pharmaceutical Other Stockholders Equity Historical Data

The historical data trend for Chong Kun Dang Pharmaceutical's Other Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Chong Kun Dang Pharmaceutical Other Stockholders Equity Chart

Chong Kun Dang Pharmaceutical Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Other Stockholders Equity

Get a 7-Day Free Trial

1,762.50

-5,151.78

-8,566.60

-14,217.08

-8,070.16

Chong Kun Dang Pharmaceutical Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Other Stockholders Equity	Get a 7-Day Free Trial															-15,027.90	-14,995.96	-14,369.07	-8,070.16	-7,932.23

Chong Kun Dang Pharmaceutical Other Stockholders Equity Calculation

Other Stockholders Equity is instruments issued by the company that cannot be identified by other specific items in the Equity section. GuruFocus lists following items in "Total Stockholders Equity" section:
Common Stock
Preferred Stock
Retained Earnings
Accumulated other comprehensive income (loss)
Additional Paid-In Capital
Treasury Stock
Other Stockholders Equity

Chong Kun Dang Pharmaceutical Other Stockholders Equity Related Terms

Thank you for viewing the detailed overview of Chong Kun Dang Pharmaceutical's Other Stockholders Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

Chong Kun Dang Pharmaceutical (XKRX:185750) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Chong Kun Dang Pharmaceutical Corp (XKRX:185750) » Definitions » Other Stockholders Equity

Traded in Other Exchanges

N/A

Address

368 Chungjungro-3Ga, Seodaemun-gu, Seoul, KOR, 120-756

Website

http://chongkundang.en.ec21.com

Chong Kun Dang Pharmaceutical Corp. is a manufacturer of antibiotics. The company manufactures and distributes over 130 ethical, OTC pharmaceuticals and pharmaceutical active ingredients, primarily focusing on the application of its advanced technologies in fermentation and organic synthesis. The product range includes Rifampicin (antituberculosis), DMCT (raw material for Minocycline), Cephalosporins, 7-ACA and other intermediates of Cephalosporins, Cyclosporin A (immunosuppressant) and Lovastatin (antihyperlipidaemic agent).

Chong Kun Dang Pharmaceutical (XKRX:185750) Headlines

No Headlines